- Home
- SCTX vs FAX Comparison
SCTX vs FAX Comparison
Compare SCTX & FAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SCTX | FAX |
|---|---|---|
| Founded | 2017 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.5M | 594.5M |
| IPO Year | 2026 | N/A |
Fundamental Metrics
Financial Performance| Metric | SCTX | FAX |
|---|---|---|
| Price | $15.56 | $12.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $57.00 | N/A |
| AVG Volume (30 Days) | ★ 415.3K | 244.0K |
| Earning Date | 11-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.09% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.50 | $12.57 |
| 52 Week High | $39.60 | $16.37 |
Technical Indicators
Market Signals| Indicator | SCTX | FAX |
|---|---|---|
| Relative Strength Index (RSI) | 34.14 | 34.83 |
| Support Level | $13.50 | $12.58 |
| Resistance Level | $22.07 | $14.69 |
| Average True Range (ATR) | 2.40 | 0.14 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 7.62 | 48.24 |
Price Performance
Historical ComparisonAbout SCTX Scribe Therapeutics Inc. Common Stock
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
About FAX abrdn Asia-Pacific Income Fund Inc.
Aberdeen Asia-pacific Income Fund Inc is a United States-based closed-end, non-diversified management investment company. Its principal investment objective is to seek current income along with capital appreciation. The fund invests in Asian debt securities, Australian debt securities, European debt securities and others.